All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations for the U.S. Medicare health…
Browsing: Hot headlines in GI
Health insurance company Cigna has agreed to pay over $172 million to settle federal allegations that it knowingly submitted false…
The FDA has granted de novo clearance to ProciseDx Inc. for its therapeutic drug monitoring tests for Humira and Remicade,…
Alcohol-associated liver disease, one of the most common types of liver disease worldwide, is associated with tremendous morbidity, mortality, and…
A recent study has found that the use of glucagon-like peptide 1 (GLP-1) agonists for weight loss, when compared with…
United Digestive (UD) is pleased to announce that Mark E. Murphy, MD, FACP, AGAF, from Center for Digestive & Liver…
Precede Biosciences, a liquid biopsy company, has come out of stealth mode with a financing of $57 million. The company’s…
The FDA has granted approval to Abrilada, making it the second interchangeable biosimilar to adalimumab. This decision allows Abrilada (adalimumab-afzb,…
Robert Schoen, MD, and Dhiraj Yadav, MD — professors at the University of Pittsburgh School of Medicine — received 2024…
JERUSALEM (Reuters) – Teva Pharmaceutical Industries will collaborate with French drugmaker Sanofi to develop a treatment for inflammatory bowel disease…